| Name | Title | Contact Details |
|---|---|---|
Ishan Tsay |
Director, Software Products | Profile |
Surekha Karudapuram |
VP, Product Management and Marketing | Profile |
Ryan Walters |
Chief Product Officer | Profile |
Holly Baden-Tillson |
Vice President of Customer Experience | Profile |
Lissa Nakhwa |
Director of Marketing | Profile |
Morphotek is a Exton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. While traditional immunotherapy discovery methods have largely used predictive methods to propose T cell targets, or antigens, Genocea has successfully developed ATLAS™, its proprietary technology platform, to identify clinically relevant antigens of T cells based on actual human immune responses. Genocea is currently using ATLAS in immuno-oncology applications to develop neoantigen cancer vaccines, general cancer vaccines and a vaccine targeting cancers caused by Epstein-Barr Virus.
CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea.
Theralogix is a Holmes, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.